Literature DB >> 22595447

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Stella S Daskalopoulou1, Nadia A Khan, Robert R Quinn, Marcel Ruzicka, Donald W McKay, Daniel G Hackam, Simon W Rabkin, Doreen M Rabi, Richard E Gilbert, Raj S Padwal, Martin Dawes, Rhian M Touyz, Tavis S Campbell, Lyne Cloutier, Steven Grover, George Honos, Robert J Herman, Ernesto L Schiffrin, Peter Bolli, Thomas Wilson, Ross D Feldman, M Patrice Lindsay, Brenda R Hemmelgarn, Michael D Hill, Mark Gelfer, Kevin D Burns, Michel Vallée, G V Ramesh Prasad, Marcel Lebel, Donna McLean, J Malcolm O Arnold, Gordon W Moe, Jonathan G Howlett, Jean-Martin Boulanger, Pierre Larochelle, Lawrence A Leiter, Charlotte Jones, Richard I Ogilvie, Vincent Woo, Janusz Kaczorowski, Luc Trudeau, Simon L Bacon, Robert J Petrella, Alain Milot, James A Stone, Denis Drouin, Maxime Lamarre-Cliché, Marshall Godwin, Guy Tremblay, Pavel Hamet, George Fodor, S George Carruthers, George Pylypchuk, Ellen Burgess, Richard Lewanczuk, George K Dresser, Brian Penner, Robert A Hegele, Philip A McFarlane, Mukul Sharma, Norman R C Campbell, Debra Reid, Luc Poirier, Sheldon W Tobe.   

Abstract

We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2012. The new recommendations are: (1) use of home blood pressure monitoring to confirm a diagnosis of white coat syndrome; (2) mineralocorticoid receptor antagonists may be used in selected patients with hypertension and systolic heart failure; (3) a history of atrial fibrillation in patients with hypertension should not be a factor in deciding to prescribe an angiotensin-receptor blocker for the treatment of hypertension; and (4) the blood pressure target for patients with nondiabetic chronic kidney disease has now been changed to < 140/90 mm Hg from < 130/80 mm Hg. We also reviewed the recent evidence on blood pressure targets for patients with hypertension and diabetes and continue to recommend a blood pressure target of less than 130/80 mm Hg.
Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22595447     DOI: 10.1016/j.cjca.2012.02.018

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  60 in total

1.  Methods of defining hypertension in electronic medical records: validation against national survey data.

Authors:  Mingkai Peng; Guanmin Chen; Gilaad G Kaplan; Lisa M Lix; Neil Drummond; Kelsey Lucyk; Stephanie Garies; Mark Lowerison; Samuel Weibe; Hude Quan
Journal:  J Public Health (Oxf)       Date:  2015-11-06       Impact factor: 2.341

2.  The 2012-2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Authors:  Sherilyn K D Houle; Raj Padwal; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2013-05

Review 3.  Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes.

Authors:  Doreen M Rabi; Raj Padwal; Sheldon W Tobe; Richard E Gilbert; Lawrence A Leiter; Robert R Quinn; Nadia Khan
Journal:  CMAJ       Date:  2013-06-03       Impact factor: 8.262

Review 4.  Differences in coronary blood flow in aortic regurgitation and systemic arterial hypertension have implications for diastolic blood pressure targets: a systematic review and meta-analysis.

Authors:  Simon W Rabkin
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

5.  Personalized medicine for osteoarthritis: where are we now?

Authors:  Allen Dale Sawitzke
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-04       Impact factor: 5.346

6.  Pragmatic Method Using Blood Pressure Diaries to Assess Blood Pressure Control.

Authors:  James E Sharman; Leigh Blizzard; Wojciech Kosmala; Mark R Nelson
Journal:  Ann Fam Med       Date:  2016 Jan-Feb       Impact factor: 5.166

7.  The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.

Authors:  Finlay A McAlister; Cynthia Robitaille; Cathleen Gillespie; Keming Yuan; Deepa P Rao; Steven Grover; Sulan Dai; Helen Johansen; Michel Joffres; Fleetwood Loustalot; Norm Campbell
Journal:  Can J Cardiol       Date:  2013-03-01       Impact factor: 5.223

Review 8.  What is the ideal blood pressure goal for patients with diabetes mellitus and nephropathy?

Authors:  Mark L Lipman; Ernesto L Schiffrin
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

9.  A Prospective Real World Experience of Moxonidine Use in Indian Hypertensive Patients-Prescription beyond Current Guidelines.

Authors:  Suresh V Sagarad; Sudha Biradar-Kerure; Ramakrishna Mr; Chaitanya Kumar S; S S Reddy
Journal:  J Clin Diagn Res       Date:  2013-10-05

10.  Pay-for-performance remuneration for pharmacist prescribers' management of hypertension: A substudy of the RxACTION trial.

Authors:  Sherilyn K D Houle; Theresa L Charrois; Finlay A McAlister; Michael R Kolber; Meagen M Rosenthal; Richard Lewanczuk; Norman R C Campbell; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2016-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.